Corrigendum to: Serotonin syndrome induced by augmentation of SSRI with methylphenidate (Psychiatry and Clinical Neurosciences, (2008), 62, 2, (246), 10.1111/j.1440-1819.2008.01767.x);Serotonin syndrome induced by augmentation of SSRI with methylphenidate

Psychiatry and Clinical Neurosciences

Volumn 62, Issue 2, 2008, Pages 246-

  Ishii, Motoyasu ^a   Tatsuzawa, Yoshitaka ^a   Yoshino, Aihide ^a   Nomura, Soichiro ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXAPINE; METHYLPHENIDATE; MILNACIPRAN; PAROXETINE; SERTRALINE;

ADULT; BRAIN INFARCTION; CASE REPORT; DIAPHORESIS; DISEASE COURSE; DISEASE SEVERITY; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; FEMALE; FEVER; HUMAN; HYPERTENSION; LETTER; MAJOR DEPRESSION; MUSCLE RIGIDITY; MYDRIASIS; SEROTONIN SYNDROME; SIDE EFFECT; SYMPTOM; TACHYCARDIA; TENDON REFLEX;

EID: 42149177278     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/pcn.12961     Document Type: Erratum

References (4)

1. Lavretsky H, Kim MD, Kumar A, Reynolds CF 3rd. Combined treatment with methylphenidate and citalopram for accelerated response in the elderly: An open trial. J. Clin. Psychiatry 2003 64 : 1410 1414.
2. Boyer EW, Shannon M. The serotonin syndrome. N. Engl. J. Med. 2005 352 : 1112 1120.
3. Mason PJ, Morris VA, Balcezak TJ. Serotonin syndrome. Presentation of 2 cases and review of the literature. Medicine 2000 79 : 201 209.
4. Kuczenski R, Segal DS. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: Comparison with amphetamine. J. Neurochem. 1997 68 : 2032 2037.